| scholarly article | Q13442814 |
| P50 | author | Marco Colonna | Q37377244 |
| Marina Cella | Q55278809 | ||
| William Vermi | Q56769710 | ||
| Fabio Facchetti | Q56855361 | ||
| Karel Otero | Q114780602 | ||
| P2093 | author name string | Jason C Mills | |
| Anja Fuchs | |||
| Jason M Doherty | |||
| Jochen K M Lennerz | |||
| P2860 | cites work | IL-21 and TGF-beta are required for differentiation of human T(H)17 cells | Q37383051 |
| Interleukin-22 activates STAT3 and induces IL-10 by colon epithelial cells. | Q40560646 | ||
| Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the alpha E beta 7 integrin | Q41429601 | ||
| A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses | Q60035686 | ||
| Nonlymphoid intraepidermal mononuclear cell collections (pseudo-Pautrier abscesses): a morphologic and immunophenotypical characterization | Q73500745 | ||
| The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4 | Q80737734 | ||
| Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides | Q24303817 | ||
| TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function | Q24314628 | ||
| The biological functions of T helper 17 cell effector cytokines in inflammation | Q24614431 | ||
| NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis | Q24647094 | ||
| The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat | Q24648890 | ||
| The T-cell lymphokine interleukin-26 targets epithelial cells through the interleukin-20 receptor 1 and interleukin-10 receptor 2 chains | Q28265025 | ||
| Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor | Q28273769 | ||
| Cutting edge: CD96 (tactile) promotes NK cell-target cell adhesion by interacting with the poliovirus receptor (CD155) | Q28610418 | ||
| Development, cytokine profile and function of human interleukin 17-producing helper T cells | Q29617131 | ||
| Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens | Q29617432 | ||
| Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells | Q29618163 | ||
| IL-17 family cytokines and the expanding diversity of effector T cell lineages | Q29619361 | ||
| The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins | Q29620097 | ||
| Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis | Q29620506 | ||
| Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells | Q29622847 | ||
| Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma | Q33319277 | ||
| IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia | Q33984033 | ||
| The biology of human natural killer-cell subsets | Q34430869 | ||
| Organogenesis of lymphoid tissues | Q35096187 | ||
| NK cell compartments and their activation by dendritic cells | Q35634241 | ||
| Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation | Q36291657 | ||
| IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis | Q36303708 | ||
| Common mechanisms for the regulation of B cell differentiation and transformation by the transcriptional repressor protein BCL-6. | Q36943399 | ||
| Th17 T cells: linking innate and adaptive immunity | Q37006577 | ||
| P433 | issue | 7230 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 722-5 | |
| P577 | publication date | 2009-02-05 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity | |
| P478 | volume | 457 |
| Q42874171 | A Molecular Link Between Interleukin 22 and Intestinal Mucosal Wound Healing |
| Q36970818 | A Progenitor Cell Expressing Transcription Factor RORγt Generates All Human Innate Lymphoid Cell Subsets |
| Q43905966 | A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells |
| Q35621970 | A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease |
| Q39031358 | A committed precursor to innate lymphoid cells |
| Q43738079 | A complex issue on CD4(+) T-cell subsets |
| Q92437547 | A hierarchical role of IL-25 in ILC development and function at the lung mucosae following viral-vector vaccination |
| Q34076369 | A novel mucosal RORγtNKp46 cell subset is a source of interleukin-22. |
| Q53497403 | A novel population of human CD56+ human leucocyte antigen D-related (HLA-DR+) colonic lamina propria cells is associated with inflammation in ulcerative colitis. |
| Q48023237 | A review article on brodalumab in the treatment of moderate-to-severe plaque psoriasis |
| Q26851559 | A role for Th17 cells in the regulation of tertiary lymphoid follicles |
| Q52628213 | A role for mucosal IL-22 production and Th22 cells in HIV-associated mucosal immunopathogenesis. |
| Q38008350 | AHR and the Transcriptional Regulation of Type-17/22 ILC. |
| Q36309139 | AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch |
| Q34144406 | Activated group 3 innate lymphoid cells promote T-cell-mediated immune responses |
| Q51751177 | Activation of Type 3 innate lymphoid cells and interleukin 22 secretion in the lungs during Streptococcus pneumoniae infection. |
| Q35208507 | Activation of intestinal epithelial Stat3 orchestrates tissue defense during gastrointestinal infection |
| Q56797791 | Acute paracoccidioidomycosis with duodenal and cutaneous involvement and obstructive jaundice |
| Q37087265 | Altered distribution of mucosal NK cells during HIV infection. |
| Q37871646 | Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system |
| Q98159044 | Ambiguous roles and potential therapeutic strategies of innate lymphoid cells in different types of tumor |
| Q91971683 | An Historical Overview: The Discovery of How NK Cells Can Kill Enemies, Recruit Defense Troops, and More |
| Q38964535 | An in vitro model of innate lymphoid cell function and differentiation. |
| Q38233854 | An overview of the role of innate lymphoid cells in gut infections and inflammation |
| Q37244321 | Another earth: innate lymphoid cells and intestinal inflammation |
| Q24642507 | Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity |
| Q37225169 | Antiretroviral therapy partly reverses the systemic and mucosal distribution of NK cell subsets that is altered by SIVmac₂₅₁ infection of macaques |
| Q34969719 | Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation |
| Q26853011 | Aryl hydrocarbon receptor: a molecular link between postnatal lymphoid follicle formation and diet |
| Q38151057 | At the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias |
| Q34135558 | Averting inflammation by targeting the cytokine environment |
| Q35784554 | B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage. |
| Q34819635 | B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response |
| Q47135898 | Bacillus anthracis lethal toxin negatively modulates ILC3 function through perturbation of IL-23-mediated MAPK signaling. |
| Q90140594 | Bacterial Infection Allows for Functional Examination of Adoptively Transferred Mouse Innate Lymphoid Cell Subsets |
| Q26865509 | Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer |
| Q33759935 | Beyond NK cells: the expanding universe of innate lymphoid cells. |
| Q38753752 | Biological and pathological activities of interleukin-22. |
| Q28084474 | Boosting vaccine efficacy the natural (killer) way |
| Q37866633 | Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. |
| Q40096897 | Bovine cryptosporidiosis: impact, host-parasite interaction and control strategies. |
| Q96952258 | Brg1 restrains the pro-inflammatory properties of ILC3s and modulates intestinal immunity |
| Q38975719 | Brodalumab for the treatment of psoriasis |
| Q37012341 | CC Chemokine Ligand 20 and Its Cognate Receptor CCR6 in Mucosal T Cell Immunology and Inflammatory Bowel Disease: Odd Couple or Axis of Evil? |
| Q36980670 | CCR6 as a possible therapeutic target in psoriasis |
| Q37286597 | CCR6 is required for IL-23-induced psoriasis-like inflammation in mice |
| Q37599020 | CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype |
| Q44346728 | CD117⁺ CD3⁻ CD56⁻ OX40Lhigh cells express IL-22 and display an LTi phenotype in human secondary lymphoid tissues. |
| Q51869989 | CD11b and CD27 reflect distinct population and functional specialization in human natural killer cells. |
| Q34144149 | CD1d-unrestricted NKT cells are endowed with a hybrid function far superior than that of iNKT cells |
| Q36622318 | CD4(+) T-cell subsets and host defense in the lung |
| Q34562235 | CD4(+) lymphoid tissue-inducer cells promote innate immunity in the gut. |
| Q33597507 | CD94 surface density identifies a functional intermediary between the CD56bright and CD56dim human NK-cell subsets |
| Q36499693 | CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium |
| Q33964256 | CX₃CR1⁺ mononuclear phagocytes support colitis-associated innate lymphoid cell production of IL-22. |
| Q37194665 | Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice |
| Q40183418 | Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer |
| Q39364287 | Cell-mediated autophagy promotes cancer cell survival. |
| Q37783746 | Cellular and Molecular Requirements in Lymph Node and Peyer's Patch Development |
| Q31034892 | Characterization and Quantification of Innate Lymphoid Cell Subsets in Human Lung |
| Q88479050 | Characterization and biological significance of IL-23-induced neutrophil polarization |
| Q90093161 | Characterization of Rat ILCs Reveals ILC2 as the Dominant Intestinal Subset |
| Q51017186 | Characterization of immunocompetent cells in human milk of Han Chinese. |
| Q37652760 | Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis |
| Q38144211 | Chemokine receptors in psoriasis |
| Q26774619 | Chemokine/chemokine receptor pair CCL20/CCR6 in human colorectal malignancy: An overview |
| Q38018702 | Chemokines and NK cells: regulators of development, trafficking and functions. |
| Q47164996 | Circulating CCL20 as a New Biomarker of Abdominal Aortic Aneurysm. |
| Q50097654 | Citrobacter rodentium Infection Model for the Analysis of Bacterial Pathogenesis and Mucosal Immunology. |
| Q47596967 | Clinical importance of IL-22 cascade in IBD. |
| Q38079585 | Clinical relevance of natural killer cells following hematopoietic stem cell transplantation |
| Q64102152 | Commensal and Pathogenic Bacteria Indirectly Induce IL-22 but Not IFNγ Production From Human Colonic ILC3s via Multiple Mechanisms |
| Q34502663 | Complementarity and redundancy of IL-22-producing innate lymphoid cells. |
| Q39012808 | Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. |
| Q35126671 | Conjunctival scarring in trachoma is associated with the HLA-C ligand of KIR and is exacerbated by heterozygosity at KIR2DL2/KIR2DL3. |
| Q35067850 | Consumption of Lactobacillus casei fermented milk prevents Salmonella reactive arthritis by modulating IL-23/IL-17 expression |
| Q37851543 | Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells |
| Q37716155 | Conventional NK cells can produce IL-22 and promote host defense in Klebsiella pneumoniae pneumonia |
| Q39256177 | Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease |
| Q35785264 | Cross-talk between type 3 innate lymphoid cells and the gut microbiota in inflammatory bowel disease |
| Q90745225 | Current Developments in the Immunology of Psoriasis |
| Q50317364 | Cytokine Networks between Innate Lymphoid Cells and Myeloid Cells. |
| Q42119341 | Cytokine Signatures in Mucocutaneous and Ocular Behçet's Disease |
| Q38303479 | Cytokine crowdsourcing: multicellular production of TH17-associated cytokines |
| Q34249937 | Cytokine requirements for the differentiation and expansion of IL-17A- and IL-22-producing human Vgamma2Vdelta2 T cells. |
| Q38857894 | Cytokine responses and epithelial function in the intestinal mucosa |
| Q36895427 | Cytokine signaling in the differentiation of innate effector cells |
| Q27007655 | Cytokine-induced cytokine production by conventional and innate lymphoid cells |
| Q39028574 | Cytokines IL-17 and IL-22 in the host response to infection |
| Q93269704 | Cytokines regulate the antigen-presenting characteristics of human circulating and tissue-resident intestinal ILCs |
| Q41602358 | Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis. |
| Q30525576 | DBA-lectin reactivity defines mouse uterine natural killer cell subsets with biased gene expression |
| Q34055620 | DOCK8 regulates protective immunity by controlling the function and survival of RORγt+ ILCs |
| Q64079803 | Deciphering the Roles of Innate Lymphoid Cells in Cancer |
| Q26861554 | Deciphering the transcriptional switches of innate lymphoid cell programming: the right factors at the right time |
| Q40312759 | Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. |
| Q37413057 | Dendritic cell interactions with NK cells from different tissues |
| Q35190718 | Dendritic cell-epithelial cell crosstalk in the gut. |
| Q33816393 | Dendritic cells produce CXCL13 and participate in the development of murine small intestine lymphoid tissues |
| Q38158411 | Dengue virus infection: current concepts in immune mechanisms and lessons from murine models |
| Q28071695 | Development and Function of Secondary and Tertiary Lymphoid Organs in the Small Intestine and the Colon |
| Q37968301 | Development and evolution of RORγt+ cells in a microbe's world |
| Q38200397 | Development and regulation of RORγt(+) innate lymphoid cells |
| Q34924388 | Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissue |
| Q38252608 | Development, differentiation, and diversity of innate lymphoid cells |
| Q36922081 | Developmental Acquisition of Regulomes Underlies Innate Lymphoid Cell Functionality |
| Q61448104 | Dietary Habits and Intestinal Immunity: From Food Intake to CD4 T Cells |
| Q90287020 | Differential Effect of Mucosal NKp44+ Innate Lymphoid Cells and Δγ Cells on Simian Immunodeficiency Virus Infection Outcome in Rhesus Macaques |
| Q43752438 | Differential recruitment and activation of natural killer cell sub-populations by Mycobacterium bovis-infected dendritic cells. |
| Q38587657 | Differentiation and function of group 3 innate lymphoid cells, from embryo to adult |
| Q34422205 | Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens |
| Q48300283 | Dissecting human ILC heterogeneity: more than just three subsets. |
| Q36478247 | Distinct requirements for T-bet in gut innate lymphoid cells |
| Q37619324 | Distribution of immune cells in the human cervix and implications for HIV transmission |
| Q38890993 | Diversity and function of group 1 innate lymphoid cells |
| Q57194260 | Dual Role of IL-22 in Allergic Airway Inflammation and its Cross-talk with IL-17A |
| Q49163994 | Dual roles of IL-22 at ischemia-reperfusion injury and acute rejection stages of rat allograft liver transplantation. |
| Q34126743 | Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy |
| Q28075218 | Dysregulation of Group 3 Innate Lymphoid Cells in the Pathogenesis of Inflammatory Bowel Disease |
| Q42208838 | Early initiation of combined antiretroviral therapy preserves immune function in the gut of HIV-infected patients. |
| Q57257173 | Editorial overview |
| Q38207947 | Effect of tumor cells and tumor microenvironment on NK-cell function. |
| Q34142426 | Effects of mycobacteria major secretion protein, Ag85B, on allergic inflammation in the lung |
| Q35906051 | Emerging Role of Interleukin 22 in Hepatitis B Virus Infection: a Double-edged Sword |
| Q37730867 | Emerging role of interleukin-22 in autoimmune diseases |
| Q37028324 | Emerging roles for antigen presentation in establishing host-microbiome symbiosis |
| Q42233193 | Enteric mucosa integrity in the presence of a preserved innate interleukin 22 compartment in HIV type 1-treated individuals |
| Q28391625 | Environmental Immunology: Lessons Learned from Exposure to a Select Panel of Immunotoxicants |
| Q36644637 | Epigenetic regulation of NK cell differentiation and effector functions |
| Q47157539 | Epigenomic Views of Innate Lymphoid Cells |
| Q40216623 | Epithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation. |
| Q37774241 | Epithelial decision makers: in search of the 'epimmunome'. |
| Q36080691 | Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity. |
| Q64258284 | Expansion of Interleukin-22- and Granulocyte-Macrophage Colony-Stimulating Factor-Expressing, but Not Interleukin-17A-Expressing, Group 3 Innate Lymphoid Cells in the Inflamed Joints of Patients With Spondyloarthritis |
| Q33934522 | Expansion of human NK-22 cells with IL-7, IL-2, and IL-1beta reveals intrinsic functional plasticity |
| Q36900160 | Expansion of inflammatory innate lymphoid cells in patients with common variable immune deficiency |
| Q41426315 | Expression of Interleukin-26 is upregulated in inflammatory bowel disease |
| Q34371302 | Expression of interleukin-22 and its significance in the pathogenesis of chronic rhinosinusitis |
| Q35647194 | Expression of interleukin-22 in Sjögren's syndrome: significant correlation with disease parameters |
| Q35816249 | Expression of interleukin-22 in decidua of patients with early pregnancy and unexplained recurrent pregnancy loss |
| Q36819589 | Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis |
| Q51665729 | Expression of retinoid-related orphan receptor (ROR)γt on NK22 cells in the peripheral blood and uterine endometrium of women with unexplained recurrent pregnancy loss and unexplained infertility. |
| Q39000564 | Expression variability and function of the RET gene in adult peripheral blood mononuclear cells |
| Q35546855 | Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor |
| Q39425975 | Fetal CD103+ IL-17-Producing Group 3 Innate Lymphoid Cells Represent the Dominant Lymphocyte Subset in Human Amniotic Fluid. |
| Q92803637 | Flagellin hypervariable region determines symbiotic properties of commensal Escherichia coli strains |
| Q37611966 | Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22 |
| Q60947680 | From Bench to Clinic: the Potential of Therapeutic Targeting of the IL-22 Signaling Pathway in Atopic Dermatitis |
| Q41838358 | Functional Differences between Human NKp44(-) and NKp44(+) RORC(+) Innate Lymphoid Cells |
| Q39034173 | Functional and phenotypic heterogeneity of group 3 innate lymphoid cells |
| Q92215594 | Functional interactions between innate lymphoid cells and adaptive immunity |
| Q36516875 | Functional perturbation of classical natural killer and innate lymphoid cells in the oral mucosa during SIV infection |
| Q35854795 | Functions of innate immune cells and commensal bacteria in gut homeostasis |
| Q97518593 | GM-CSF Calibrates Macrophage Defense and Wound Healing Programs during Intestinal Infection and Inflammation |
| Q37576715 | Gata3 drives development of RORγt+ group 3 innate lymphoid cells. |
| Q38019320 | Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapy |
| Q29616350 | Genetics and pathogenesis of inflammatory bowel disease |
| Q37067094 | Gluten-sensitive enteropathy coincides with decreased capability of intestinal T cells to secrete IL-17 and IL-22 in a macaque model for celiac disease |
| Q64071688 | Group 3 ILCs: Peacekeepers or Troublemakers? What's Your Gut Telling You?! |
| Q47138366 | Group 3 Innate Lymphoid Cells: Communications Hubs of the Intestinal Immune System |
| Q28081074 | Group 3 innate lymphoid cells (ILC3s): Origin, differentiation, and plasticity in humans and mice |
| Q36479985 | Group 3 innate lymphoid cells continuously require the transcription factor GATA-3 after commitment |
| Q37448373 | Group 3 innate lymphoid cells inhibit T-cell-mediated intestinal inflammation through aryl hydrocarbon receptor signaling and regulation of microflora. |
| Q39975755 | Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua |
| Q38602944 | Group 3 innate lymphoid cells: regulating host-commensal bacteria interactions in inflammation and cancer |
| Q39167526 | Guards at the gate: physiological and pathological roles of tissue-resident innate lymphoid cells in the lung |
| Q41918189 | Guidelines for the use of flow cytometry and cell sorting in immunological studies |
| Q36132003 | Gut Mucosal Barrier Dysfunction, Microbial Dysbiosis, and Their Role in HIV-1 Disease Progression |
| Q35230224 | Gut inflammation and indoleamine deoxygenase inhibit IL-17 production and promote cytotoxic potential in NKp44+ mucosal NK cells during SIV infection |
| Q92154266 | HCMV Infection in a Mesenchymal Stem Cell Niche: Differential Impact on the Development of NK Cells versus ILC3 |
| Q37683137 | HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation. |
| Q37152701 | Hallmarks of Tissue-Resident Lymphocytes |
| Q59128967 | Hallmarks of primate lentiviral immunodeficiency infection recapitulate loss of innate lymphoid cells |
| Q37867487 | Harnessing the biology of IL-7 for therapeutic application |
| Q37987526 | Healing of intestinal inflammation by IL-22. |
| Q38606216 | Heterogeneity and diversity of group 3 innate lymphoid cells: new cells on the block |
| Q37578374 | Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity |
| Q34127431 | Heterogeneity of IL-22-producing Lymphoid Tissue Inducer-like Cells in Human and Mouse |
| Q64244231 | Heterogeneity of NK Cells and Other Innate Lymphoid Cells in Human and Murine Decidua |
| Q93063965 | Heterogeneity of human bone marrow and blood natural killer cells defined by single-cell transcriptome |
| Q37381928 | Hidden talents of natural killers: NK cells in innate and adaptive immunity |
| Q33577368 | Highlights of the advances in basic immunology in 2011. |
| Q36923759 | Homeostatic PPARα Signaling Limits Inflammatory Responses to Commensal Microbiota in the Intestine. |
| Q36295242 | Host-microbiota interactions in inflammatory bowel disease |
| Q39095221 | Host-microbiota interactions: epigenomic regulation |
| Q36910650 | Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection |
| Q26742158 | Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations |
| Q64067984 | Human Gut-Associated Natural Killer Cells in Health and Disease |
| Q84933191 | Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161 |
| Q33564666 | Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production |
| Q40735418 | Human Lymphoid Tissues Harbor a Distinct CD69+CXCR6+ NK Cell Population. |
| Q42915172 | Human NKp44+IL-22+ cells and LTi-like cells constitute a stable RORC+ lineage distinct from conventional natural killer cells |
| Q34290773 | Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection |
| Q85926211 | Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues |
| Q37410808 | Human uterine natural killer cells but not blood natural killer cells inhibit human immunodeficiency virus type 1 infection by secretion of CXCL12. |
| Q27322468 | Hypercytotoxicity and rapid loss of NKp44+ innate lymphoid cells during acute SIV infection |
| Q55657572 | Hypoxia, Metabolism and Immune Cell Function. |
| Q40652847 | ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice |
| Q37974986 | IL-10 and IL-10 receptor defects in humans. |
| Q37809207 | IL-17 family member cytokines: regulation and function in innate immunity. |
| Q36985422 | IL-17-producing innate lymphoid cells are restricted to mucosal tissues and are depleted in SIV-infected macaques |
| Q38040743 | IL-17-producing γδ T cells and innate lymphoid cells |
| Q38129869 | IL-17A and Th17 cells in lung inflammation: an update on the role of Th17 cell differentiation and IL-17R signaling in host defense against infection. |
| Q40069845 | IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB. |
| Q41109227 | IL-1β inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors. |
| Q42321500 | IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells |
| Q53793238 | IL-1β, IL-4 and IL-12 control the fate of group 2 innate lymphoid cells in human airway inflammation in the lungs. |
| Q47758483 | IL-22 Increases Permeability of Intestinal Epithelial Tight Junctions by Enhancing Claudin-2 Expression. |
| Q35928387 | IL-22 Protects Against Liver Pathology and Lethality of an Experimental Blood-Stage Malaria Infection |
| Q64234330 | IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure |
| Q46485022 | IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium |
| Q30539616 | IL-22 deficiency alters colonic microbiota to be transmissible and colitogenic. |
| Q51054891 | IL-22 defines a novel immune pathway of antifungal resistance. |
| Q42875392 | IL-22 from conventional NK cells is epithelial regenerative and inflammation protective during influenza infection |
| Q37832449 | IL-22 in antifungal immunity |
| Q37228800 | IL-22 in the endometriotic milieu promotes the proliferation of endometrial stromal cells via stimulating the secretion of CCL2 and IL-8 |
| Q57194265 | IL-22 is produced by γC-independent CD25+ CCR6+ innate murine spleen cells upon inflammatory stimuli and contributes to LPS-induced lethality |
| Q41147927 | IL-22 is rapidly induced by Pathogen Recognition Receptors Stimulation in Bone-Marrow-derived Dendritic Cells in the Absence of IL-23. |
| Q39034933 | IL-22 modulates IL-17A production and controls inflammation and tissue damage in experimental dengue infection |
| Q33604771 | IL-22 negatively regulates Helicobacter pylori-induced CCL20 expression in gastric epithelial cells |
| Q39391390 | IL-22 promotes fibroblast-mediated wound repair in the skin |
| Q33655332 | IL-22(+)CD4(+) T cells promote colorectal cancer stemness via STAT3 transcription factor activation and induction of the methyltransferase DOT1L |
| Q38081171 | IL-22, not simply a Th17 cytokine |
| Q36474946 | IL-22-Expressing Murine Lymphocytes Display Plasticity and Pathogenicity in Reporter Mice |
| Q42920577 | IL-22-producing CD4+ T cells: middle-men between the immune system and its environment |
| Q37068500 | IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis. |
| Q38079587 | IL-22: An Evolutionary Missing-Link Authenticating the Role of the Immune System in Tissue Regeneration |
| Q37393834 | IL-22: a critical mediator in mucosal host defense |
| Q37366047 | IL-23 induces IL-22 and IL-17 production in response to Chlamydia muridarum genital tract infection, but the absence of these cytokines does not influence disease pathogenesis |
| Q33929197 | IL-23 suppresses innate immune response independently of IL-17A during carcinogenesis and metastasis |
| Q87973501 | IL-23-induced macrophage polarization and its pathological roles in mice with imiquimod-induced psoriasis |
| Q38423061 | IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease |
| Q34440569 | IL-26 is overexpressed in rheumatoid arthritis and induces proinflammatory cytokine production and Th17 cell generation |
| Q64252468 | IL-26, a Cytokine With Roles in Extracellular DNA-Induced Inflammation and Microbial Defense |
| Q64067854 | IL-27 promotes NK cell effector functions via Maf-Nrf2 pathway during influenza infection |
| Q35685426 | IL-33-responsive lineage- CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs |
| Q37132980 | IL-6 promotes NK cell production of IL-17 during toxoplasmosis |
| Q33656197 | IL-7 and IL-15 independently program the differentiation of intestinal CD3-NKp46+ cell subsets from Id2-dependent precursors |
| Q64066256 | ILC3 function as a double-edged sword in inflammatory bowel diseases |
| Q91808408 | ILC3s integrate glycolysis and mitochondrial production of reactive oxygen species to fulfill activation demands |
| Q35843608 | Identification and Analysis of Natural Killer Cells in Murine Nasal Passages |
| Q43991749 | Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells |
| Q50041515 | Identification of an innate T helper type 17 response to intestinal bacterial pathogens. |
| Q87427344 | Identification of diverse innate lymphoid cells in human decidua |
| Q34062618 | Identification of human NK17/NK1 cells |
| Q35177247 | Identity, regulation and in vivo function of gut NKp46+RORγt+ and NKp46+RORγt- lymphoid cells |
| Q37226619 | Immature NK cells, capable of producing IL-22, are present in human uterine mucosa |
| Q39043848 | Immune Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation: Time To T Up the Thymus |
| Q35204150 | Immune mechanisms and development of childhood asthma |
| Q39000249 | Immune modules shared by innate lymphoid cells and T cells |
| Q37843649 | Immune responses to gut microbiota-commensals and pathogens |
| Q50042967 | Immunological pathogenesis of inflammatory bowel disease. |
| Q38004933 | Immunoregulation by the gut microbiota |
| Q89965683 | Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis |
| Q89975956 | In-Vitro Cell Culture for Efficient Assessment of Mycotoxin Exposure, Toxicity and Risk Mitigation |
| Q54239520 | Increased number and frequency of group 3 innate lymphoid cells in nonlesional psoriatic skin. |
| Q35754472 | Inducible innate resistance of lung epithelium to infection |
| Q91889502 | Induction of IL-22 protein and IL-22-producing cells in rainbow trout Oncorhynchus mykiss |
| Q33464362 | Induction of intestinal lymphoid tissue formation by intrinsic and extrinsic signals |
| Q45756098 | Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma. |
| Q40076719 | Inflammatory colonic innate lymphoid cells are increased during untreated hiv-1 infection and associated with markers of gut dysbiosis and mucosal immune activation. |
| Q37693528 | Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs |
| Q33608575 | Innate IL-17-producing cells: the sentinels of the immune system |
| Q34070433 | Innate Immune Natural Killer Cells and Their Role in HIV and SIV Infection |
| Q90176757 | Innate Lymphocytes in Psoriasis |
| Q47162429 | Innate Lymphoid Cells (ILCs) as Mediators of Inflammation, Release of Cytokines and Lytic Molecules |
| Q49920496 | Innate Lymphoid Cells (ILCs): Cytokine Hubs Regulating Immunity and Tissue Homeostasis. |
| Q40019073 | Innate Lymphoid Cells Are Depleted Irreversibly during Acute HIV-1 Infection in the Absence of Viral Suppression. |
| Q90092769 | Innate Lymphoid Cells at the Maternal-Fetal Interface in Human Pregnancy |
| Q47554808 | Innate Lymphoid Cells in HIV/SIV Infections |
| Q64255314 | Innate Lymphoid Cells in Mucosal Immunity |
| Q53402699 | Innate Lymphoid Cells: A Promising New Regulator in Fibrotic Diseases. |
| Q89167818 | Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity |
| Q92594507 | Innate Lymphoid Cells: Regulators of Gut Barrier Function and Immune Homeostasis |
| Q36019373 | Innate immune response to Salmonella typhimurium, a model enteric pathogen |
| Q27002611 | Innate immune signaling in defense against intestinal microbes |
| Q51743758 | Innate immunity in HIV infection and implications for vaccine design: a summary of the workshop held at the National Institute of Allergy and Infectious Diseases, Bethesda on February 25-26, 2010. |
| Q38221348 | Innate immunity in the lung regulates the development of asthma |
| Q84494196 | Innate lymphocytes induce inflammatory bowel disease |
| Q38872152 | Innate lymphoid cell function in the context of adaptive immunity |
| Q36390314 | Innate lymphoid cell interactions with microbiota: implications for intestinal health and disease |
| Q91844953 | Innate lymphoid cell memory |
| Q38712079 | Innate lymphoid cells and the MHC. |
| Q38500621 | Innate lymphoid cells are pivotal actors in allergic, inflammatory and autoimmune diseases |
| Q38872144 | Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis. |
| Q49861059 | Innate lymphoid cells at the human maternal-fetal interface in spontaneous preterm labor. |
| Q41904687 | Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. |
| Q52641247 | Innate lymphoid cells in autoimmunity and chronic inflammatory diseases. |
| Q38985676 | Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases. |
| Q89684715 | Innate lymphoid cells in inflammatory arthritis |
| Q38605374 | Innate lymphoid cells in intestinal immunity and inflammation |
| Q38810910 | Innate lymphoid cells in secondary lymphoid organs |
| Q38165175 | Innate lymphoid cells in the defense against infections |
| Q36908615 | Innate lymphoid cells in the initiation, regulation and resolution of inflammation |
| Q40063411 | Innate lymphoid cells in tissue homeostasis and diseases |
| Q37734578 | Innate lymphoid cells integrate stromal and immunological signals to enhance antibody production by splenic marginal zone B cells. |
| Q35872309 | Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus |
| Q36977474 | Innate lymphoid cells regulate CD4+ T-cell responses to intestinal commensal bacteria |
| Q36822687 | Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model |
| Q27026229 | Innate lymphoid cells, possible interaction with microbiota |
| Q29617431 | Innate lymphoid cells--a proposal for uniform nomenclature |
| Q38071916 | Innate lymphoid cells--how did we miss them? |
| Q88990558 | Innate lymphoid cells-key immune integrators of overall body homeostasis |
| Q35638915 | Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology |
| Q92560950 | Innate lymphoid cells: A potential link between microbiota and immune responses against cancer |
| Q36645149 | Innate lymphoid cells: balancing immunity, inflammation, and tissue repair in the intestine. |
| Q36059099 | Innate lymphoid cells: critical regulators of allergic inflammation and tissue repair in the lung |
| Q38077406 | Innate lymphoid cells: from border protection to the initiation of inflammatory diseases |
| Q89304826 | Innate lymphoid cells: key players in tissue-specific immunity |
| Q38643190 | Innate lymphoid cells: major players in inflammatory diseases |
| Q38916194 | Innate lymphoid cells: models of plasticity for immune homeostasis and rapid responsiveness in protection. |
| Q38622555 | Innate lymphoid cells: the role in respiratory infections and lung tissue damage |
| Q33987059 | Innate protection from graft-versus-host disease |
| Q35559739 | Inositol phospholipid signaling and the biology of natural killer cells |
| Q33956973 | Insights into IBD Pathogenesis |
| Q36512349 | Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection |
| Q33590409 | Interleukin (IL)-23 mediates Toxoplasma gondii-induced immunopathology in the gut via matrixmetalloproteinase-2 and IL-22 but independent of IL-17. |
| Q37520186 | Interleukin 22 inhibits intracellular growth of Mycobacterium tuberculosis by enhancing calgranulin A expression. |
| Q42580235 | Interleukin 22 signaling promotes cell growth in mantle cell lymphoma |
| Q90675719 | Interleukin 23 and autoimmune diseases: current and possible future therapies |
| Q38183649 | Interleukin 23 in Crohn's disease |
| Q51556893 | Interleukin 26 suppresses receptor activator of nuclear factor κB ligand induced osteoclastogenesis via down-regulation of nuclear factor of activated T-cells, cytoplasmic 1 and nuclear factor κB activity. |
| Q35833796 | Interleukin-1 (IL-1) signaling in intestinal stromal cells controls KC/ CXCL1 secretion, which correlates with recruitment of IL-22- secreting neutrophils at early stages of Citrobacter rodentium infection |
| Q26748505 | Interleukin-10 Family and Tuberculosis: An Old Story Renewed |
| Q36482702 | Interleukin-17 (IL-17) expression is reduced during acute myocardial infarction: role on chemokine receptor expression in monocytes and their in vitro chemotaxis towards chemokines |
| Q41893697 | Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. |
| Q33964145 | Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection |
| Q37624160 | Interleukin-22 Secreted by NKp44+ Natural Killer Cells Promotes Proliferation of Fibroblast-Like Synoviocytes in Rheumatoid Arthritis |
| Q26770224 | Interleukin-22 Signaling in the Regulation of Intestinal Health and Disease |
| Q54331253 | Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis. |
| Q37530484 | Interleukin-22 as a molecular adjuvant facilitates IL-17-producing CD8+ T cell responses against a HBV DNA vaccine in mice |
| Q24595764 | Interleukin-22 drives endogenous thymic regeneration in mice |
| Q24626202 | Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease |
| Q36745327 | Interleukin-22 reduces the severity of collagen-induced arthritis in association with increased levels of interleukin-10. |
| Q53139446 | Interleukin-22 regulates antimicrobial peptide expression and keratinocyte differentiation to control Staphylococcus aureus colonization of the nasal mucosa. |
| Q51752115 | Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? |
| Q38177958 | Interleukin-22: a likely target for treatment of autoimmune diseases |
| Q35530956 | Interleukin-22: immunobiology and pathology |
| Q37883457 | Interleukin-23 and T helper 17-type responses in intestinal inflammation: from cytokines to T-cell plasticity |
| Q100559315 | Interleukin-26 activates macrophages and facilitates killing of Mycobacterium tuberculosis |
| Q38552455 | Interleukin-26: An Emerging Player in Host Defense and Inflammation. |
| Q34384300 | Interleukin-26: an IL-10-related cytokine produced by Th17 cells |
| Q92538732 | Interleukin-7 Receptor Alpha in Innate Lymphoid Cells: More Than a Marker |
| Q64262246 | Interleukin‑22 regulates the homeostasis of the intestinal epithelium during inflammation |
| Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
| Q48151041 | Interplay of innate lymphoid cells and the microbiota. |
| Q37700728 | Intestinal bacteria and the regulation of immune cell homeostasis |
| Q38460376 | Intestinal barrier loss as a critical pathogenic link between inflammatory bowel disease and graft-versus-host disease |
| Q39401415 | Intestinal lymphatic vasculature: structure, mechanisms and functions |
| Q35953647 | Intestinal macrophages arising from CCR2(+) monocytes control pathogen infection by activating innate lymphoid cells. |
| Q35144584 | Intestinal microbiota and its effects on the immune system |
| Q37845442 | Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity |
| Q36790083 | Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells |
| Q47298992 | Intrahepatic and peripheral blood phenotypes of NK and T cells: Differential surface expression of KIR receptors |
| Q52588293 | Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses. |
| Q28270049 | Involvement of the IL-22/REG Ialpha axis in ulcerative colitis |
| Q40381607 | Isolation and Flow Cytometry Analysis of Innate Lymphoid Cells from the Intestinal Lamina Propria |
| Q57181210 | JAK/STAT signaling in regulation of innate lymphoid cells: The gods before the guardians |
| Q92760311 | KLRG1 and NKp46 discriminate subpopulations of human CD117+CRTH2- ILCs biased toward ILC2 or ILC3 |
| Q34371338 | L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner |
| Q57099305 | LIGHT-HVEM Signaling in Innate Lymphoid Cell Subsets Protects Against Enteric Bacterial Infection |
| Q38974225 | Lambda Interferons: New Cytokines with Old Functions |
| Q30422264 | Leptin and mucosal immunity |
| Q37612560 | Life in the inflamed intestine, Salmonella style |
| Q39217244 | Lineage relationships of human interleukin-22-producing CD56+ RORγt+ innate lymphoid cells and conventional natural killer cells |
| Q34267752 | Lineage-specific adjacent IFNG and IL26 genes share a common distal enhancer element |
| Q37326768 | Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases |
| Q37366117 | Location and cellular stages of natural killer cell development |
| Q40287938 | Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. |
| Q36237445 | Loss of mucosal CD103+ DCs and IL-17+ and IL-22+ lymphocytes is associated with mucosal damage in SIV infection |
| Q37594571 | Lymphoid tissue inducer cells: bridges between the ancient innate and the modern adaptive immune systems |
| Q37977138 | Lymphoid tissue inducer cells: innate cells critical for CD4+ T cell memory responses? |
| Q49896661 | Lymphoid tissue inducer-A divergent member of the ILC family. |
| Q33883606 | Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection |
| Q35189278 | Lymphotoxin beta receptor signaling limits mucosal damage through driving IL-23 production by epithelial cells. |
| Q36031510 | Lymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge. |
| Q37722321 | Lymphotoxin organizes contributions to host defense and metabolic illness from innate lymphoid cells |
| Q34295896 | Lymphotoxin regulates commensal responses to enable diet-induced obesity |
| Q58478653 | Lymphotoxin-β receptor-independent development of intestinal IL-22-producing NKp46+ innate lymphoid cells |
| Q64240832 | Macrophage β2-Integrins Regulate IL-22 by ILC3s and Protect from Lethal Citrobacter rodentium-Induced Colitis |
| Q26796071 | Maintenance of Immune Homeostasis through ILC/T Cell Interactions |
| Q36410178 | Mapping of NKp46(+) Cells in Healthy Human Lymphoid and Non-Lymphoid Tissues |
| Q51557011 | Mass cytometry reveals innate lymphoid cell differentiation pathways in the human fetal intestine. |
| Q35096758 | Mechanisms controlling Th17 cytokine expression and host defense |
| Q37921196 | Mechanisms of NK cell activation: CD4(+) T cells enter the scene. |
| Q37469815 | Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity |
| Q36650805 | Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells |
| Q37011716 | Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina |
| Q28391029 | Memory-Like Antigen-Specific Human NK Cells from TB Pleural Fluids Produced IL-22 in Response to IL-15 or Mycobacterium tuberculosis Antigens |
| Q34007381 | Memory-like responses of natural killer cells |
| Q33765449 | Microbes, the gut and ankylosing spondylitis |
| Q34918999 | Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. |
| Q33822367 | Microbiota-derived butyrate suppresses group 3 innate lymphoid cells in terminal ileal Peyer's patches |
| Q34532644 | Microbiota-immune system interaction: an uneasy alliance |
| Q91891671 | Microbiota-induced tissue signals regulate ILC3-mediated antigen presentation |
| Q37721588 | Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells |
| Q34022257 | Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything |
| Q37049380 | Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor. |
| Q39271596 | Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions |
| Q59387548 | Mouse models for the study of fate and function of innate lymphoid cells |
| Q37875821 | Mucocutaneous candidiasis and autoimmunity against cytokines in APECED and thymoma patients: clinical and pathogenetic implications |
| Q37736005 | Mucosal HIV vaccines: a holy grail or a dud? |
| Q37718355 | Multiple hats for natural killers |
| Q38254152 | Multiple sclerosis and the role of immune cells. |
| Q43148562 | Murine CXCR3+CD27bright NK cells resemble the human CD56bright NK-cell population |
| Q34959053 | Mutiny or scrutiny: NK cell modulation of DC function in HIV-1 infection |
| Q38833469 | NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures. |
| Q88013801 | NCR+ ILC3 maintain larger STAT4 reservoir via T-BET to regulate type 1 features upon IL-23 stimulation in mice |
| Q38715581 | NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3. |
| Q98177647 | NK Cell Development in Times of Innate Lymphoid Cell Diversity |
| Q26744632 | NK Cells and Other Innate Lymphoid Cells in Hematopoietic Stem Cell Transplantation |
| Q58606356 | NK Cells in HIV-1 Infection: From Basic Science to Vaccine Strategies |
| Q47145348 | NK cell abnormality and its treatment in women with reproductive failures such as recurrent pregnancy loss, implantation failures, preeclampsia, and pelvic endometriosis |
| Q37552129 | NK cell autoreactivity and autoimmune diseases. |
| Q37855941 | NK cell subsets and their role in allergy |
| Q37891799 | NK cells and psoriasis |
| Q34700499 | NK cells and their ability to modulate T cells during virus infections |
| Q42016732 | NK cells are required for costimulatory blockade induced tolerance to vascularized allografts |
| Q36455293 | NK cells influence both innate and adaptive immune responses after mucosal immunization with antigen and mucosal adjuvant. |
| Q36083904 | NK1.1+ cells and IL-22 regulate vaccine-induced protective immunity against challenge with Mycobacterium tuberculosis |
| Q53652932 | NK22 Cells in the Uterine Mid-Secretory Endometrium and Peripheral Blood of Women with Recurrent Pregnancy Loss and Unexplained Infertility. |
| Q57053345 | NKR-P1B expression in gut-associated innate lymphoid cells is required for the control of gastrointestinal tract infections |
| Q38362633 | NKp44 and Natural Cytotoxicity Receptors as Damage-Associated Molecular Pattern Recognition Receptors |
| Q64063119 | NKp44-NKp44 Ligand Interactions in the Regulation of Natural Killer Cells and Other Innate Lymphoid Cells in Humans |
| Q34662634 | NKp46 defines ovine cells that have characteristics corresponding to NK cells |
| Q37145726 | NKp80 Defines a Critical Step during Human Natural Killer Cell Development |
| Q52777818 | Natural Killer Cell Subsets and Their Functional Activity in Behçet's Disease. |
| Q49590083 | Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. |
| Q28251675 | Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles |
| Q36701917 | Natural cytotoxicity receptors: broader expression patterns and functions in innate and adaptive immune cells. |
| Q37568931 | Natural killer (NK) and NK-like cells at mucosal epithelia: Mediators of anti-microbial defense and maintenance of tissue integrity |
| Q37959322 | Natural killer (NK) cells in antibacterial innate immunity: angels or devils? |
| Q35830835 | Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods |
| Q38066484 | Natural killer cell distribution and trafficking in human tissues. |
| Q37929639 | Natural killer cell receptor-expressing innate lymphocytes: more than just NK cells |
| Q34818989 | Natural killer cell-triggered vascular transformation: maternal care before birth? |
| Q37124504 | Natural killer cells and their receptors in multiple sclerosis |
| Q36486204 | Natural killer cells in non-hematopoietic malignancies |
| Q36558792 | Natural killer cells protect against mucosal and systemic infection with the enteric pathogen Citrobacter rodentium |
| Q30425772 | Natural killer cells regulate murine cytomegalovirus-induced sialadenitis and salivary gland disease |
| Q37412618 | Natural killer cells: integrating diversity with function |
| Q37754682 | Natural killer cells: versatile roles in autoimmune and infectious diseases |
| Q42915163 | Natural killer receptors: the burden of a name |
| Q38075724 | New friendships and old feuds: relationships between innate lymphoid cells and microbial communities |
| Q37779724 | New insights into the development of lymphoid tissues |
| Q34089159 | Nfil3 is crucial for development of innate lymphoid cells and host protection against intestinal pathogens. |
| Q41833756 | No monkey business: why studying NK cells in non-human primates pays off. |
| Q35894203 | Notch, Id2, and RORγt sequentially orchestrate the fetal development of lymphoid tissue inducer cells |
| Q28509751 | Notch2-dependent classical dendritic cells orchestrate intestinal immunity to attaching-and-effacing bacterial pathogens |
| Q37895407 | Nuocytes: expanding the innate cell repertoire in type-2 immunity |
| Q37948124 | OX40 and CD30 signals in CD4(+) T-cell effector and memory function: a distinct role for lymphoid tissue inducer cells in maintaining CD4(+) T-cell memory but not effector function |
| Q34329075 | On the role of natural killer cells in neurodegenerative diseases |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q39250716 | Origins and evolution of innate lymphoid cells: Wardens of barrier immunity |
| Q26779745 | Pathogen Resistance Mediated by IL-22 Signaling at the Epithelial-Microbiota Interface |
| Q24597173 | Pathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A |
| Q36368544 | Patients with cystic fibrosis have inducible IL-17+IL-22+ memory cells in lung draining lymph nodes |
| Q34756285 | Perturbations of mucosal homeostasis through interactions of intestinal microbes with myeloid cells |
| Q39275772 | Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis |
| Q64102318 | Physiological Regulation of Innate Lymphoid Cells |
| Q38366661 | Pivotal roles of ILCs in hepatic diseases |
| Q36106065 | Plasmacytoid dendritic cells promote HIV-1-induced group 3 innate lymphoid cell depletion |
| Q39441262 | Plastic Heterogeneity of Innate Lymphoid Cells in Cancer |
| Q89927095 | Plasticity of innate lymphoid cell subsets |
| Q89965506 | Pleiotropic Role and Bidirectional Immunomodulation of Innate Lymphoid Cells in Cancer |
| Q33479167 | Polyclonal B cell differentiation and loss of gastrointestinal tract germinal centers in the earliest stages of HIV-1 infection |
| Q91891956 | Possible role of highly activated mucosal NK cells against viral respiratory infections in children undergoing haematopoietic stem cell transplantation |
| Q35043975 | Potential role of NK cells in the pathogenesis of inflammatory bowel disease |
| Q49942221 | Preferential Reduction of Circulating Innate Lymphoid Cells Type 2 in Patients with Common Variable Immunodeficiency with Secondary Complications Is Part of a Broader Immune Dysregulation. |
| Q89685652 | Presence of Inflammatory Group I and III Innate Lymphoid Cells in the Colon of SIV-infected Rhesus Macaques |
| Q92269146 | Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: Functional analysis and expression of PD-1 receptor |
| Q45939390 | Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. |
| Q92852963 | Programmed Cell Death-1 Receptor (PD-1)-Mediated Regulation of Innate Lymphoid Cells |
| Q91893234 | Prolactin Acts on Myeloid Progenitors to Modulate SMAD7 Expression and Enhance Hematopoietic Stem Cell Differentiation into the NK Cell Lineage |
| Q26825858 | Protective and pathological properties of IL-22 in liver disease: implications for viral hepatitis |
| Q38734006 | Protective role of Th17 cells in pulmonary infection |
| Q84007863 | Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma |
| Q54212586 | Purine metabolism controls innate lymphoid cell function and protects against intestinal injury. |
| Q46167903 | RORγt+ innate lymphoid cells regulate intestinal homeostasis by integrating negative signals from the symbiotic microbiota |
| Q38972759 | RORγt, a multitask nuclear receptor at mucosal surfaces. |
| Q35902155 | Rapid Column-Free Enrichment of Mononuclear Cells from Solid Tissues |
| Q37851777 | Recent advances in IL-22 biology. |
| Q26751223 | Recent advances in understanding psoriasis |
| Q34033579 | Reciprocal interactions of the intestinal microbiota and immune system. |
| Q38205440 | Recognition strategies of group 3 innate lymphoid cells |
| Q35205539 | Redundant and pathogenic roles for IL-22 in mycobacterial, protozoan, and helminth infections |
| Q34591589 | Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes |
| Q97521492 | Regulation of Human Innate Lymphoid Cells in the Context of Mucosal Inflammation |
| Q37442153 | Regulation of TH17 cells in the mucosal surfaces |
| Q34081391 | Regulation of intestinal health and disease by innate lymphoid cells |
| Q26864694 | Regulation of the adaptive immune system by innate lymphoid cells |
| Q54346247 | Regulation of the development of acute hepatitis by IL-23 through IL-22 and IL-17 production. |
| Q45440004 | Renal IL-17 expression in human ANCA-associated glomerulonephritis |
| Q34737528 | Retracted: IL-26 Promotes the Proliferation and Survival of Human Gastric Cancer Cells by Regulating the Balance of STAT1 and STAT3 Activation |
| Q39144086 | Review: Innate Lymphoid Cells: Sparking Inflammatory Rheumatic Disease? |
| Q38927415 | Role of AhR in positive regulation of cell proliferation and survival |
| Q49024849 | Role of NKp46+ natural killer cells in house dust mite-driven asthma. |
| Q58692418 | Role of Natural Killer Cells in Multiple Sclerosis |
| Q35054508 | Role of common-gamma chain cytokines in NK cell development and function: perspectives for immunotherapy. |
| Q27001687 | Role of group 3 innate lymphoid cells in antibody production |
| Q42150907 | Role of innate lymphocytes in infection and inflammation |
| Q49187045 | Role of innate lymphoid cells in obesity and metabolic disease (Review). |
| Q34456769 | Role of interleukin-22 in inflammatory bowel disease |
| Q37887500 | Role of natural killer and dendritic cell crosstalk in immunomodulation by commensal bacteria probiotics |
| Q38016151 | Role of the Aryl Hydrocarbon Receptor in Controlling Maintenance and Functional Programs of RORγt(+) Innate Lymphoid Cells and Intraepithelial Lymphocytes |
| Q37292408 | Role of the aryl hydrocarbon receptor (AhR) in lung inflammation |
| Q34036490 | Role of the gut microbiota in immunity and inflammatory disease |
| Q36588140 | Role of the gut microbiota in the development and function of lymphoid cells. |
| Q41249505 | Roles of IL-22 in Allergic Airway Inflammation |
| Q51097602 | Roles of RUNX Complexes in Immune Cell Development. |
| Q37926818 | Rorγt+ innate lymphoid cells in intestinal homeostasis and immunity |
| Q41953828 | STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing |
| Q38579179 | STAT3: a critical component in the response to Helicobacter pylori infection. |
| Q33797827 | Salivary gland NK cells are phenotypically and functionally unique |
| Q37322356 | Serum levels of selected Th17 and Th22 cytokines in psoriatic patients. |
| Q36765617 | Sex impacts Th1 cells, Tregs, and DCs in both intestinal and systemic immunity in a mouse strain and location-dependent manner |
| Q42551573 | Simian immunodeficiency virus infection induces expansion of alpha4beta7+ and cytotoxic CD56+ NK cells |
| Q91631661 | Spatial and Temporal Mapping of Human Innate Lymphoid Cells Reveals Elements of Tissue Specificity |
| Q63916390 | Spontaneous pulmonary hypertension in genetic mouse models of natural killer cell deficiency |
| Q46194895 | Spotlight on IL-22-producing NK cell receptor-expressing mucosal lymphocytes. |
| Q89883812 | Sputum IL-26 Is Overexpressed in Severe Asthma and Induces Proinflammatory Cytokine Production and Th17 Cell Generation: A Case-Control Study of Women |
| Q24655076 | Stage 3 immature human natural killer cells found in secondary lymphoid tissue constitutively and selectively express the TH 17 cytokine interleukin-22 |
| Q64093237 | Stage of Gestation at Porcine Epidemic Diarrhea Virus Infection of Pregnant Swine Impacts Maternal Immunity and Lactogenic Immune Protection of Neonatal Suckling Piglets |
| Q37747165 | Structure and function of interleukin-22 and other members of the interleukin-10 family |
| Q42420342 | Synovial effusion and synovial fluid biomarkers in psoriatic arthritis to assess intraarticular tumor necrosis factor-α blockade in the knee joint. |
| Q89860707 | T Helper Cells: The Modulators of Inflammation in Multiple Sclerosis |
| Q35156077 | T cell contamination in flow cytometry gating approaches for analysis of innate lymphoid cells. |
| Q38548745 | T-helper 22 cells as a new player in chronic inflammatory skin disorders. |
| Q50199704 | TAOK1 negatively regulates IL-17-mediated signaling and inflammation. |
| Q34735556 | TGF-β affects development and differentiation of human natural killer cell subsets |
| Q34694834 | TLR5 signaling stimulates the innate production of IL-17 and IL-22 by CD3(neg)CD127+ immune cells in spleen and mucosa |
| Q38584529 | Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases |
| Q38131660 | Targeting interleukin-22 in psoriasis |
| Q38548095 | Targeting the gastrointestinal tract to develop novel therapies for HIV. |
| Q38081172 | Th1- and Th2-like subsets of innate lymphoid cells |
| Q33611067 | Th17 cells at the crossroads of innate and adaptive immunity against infectious diseases at the mucosa |
| Q33943805 | Th17 cytokines in mucosal immunity and inflammation |
| Q38068964 | Th22 and related cytokines in inflammatory and autoimmune diseases |
| Q42148408 | Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria |
| Q24647357 | Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling |
| Q40101155 | The IDO-AhR Axis Controls Th17/Treg Immunity in a Pulmonary Model of Fungal Infection |
| Q28252101 | The IL-20 subfamily of cytokines--from host defence to tissue homeostasis |
| Q37989164 | The IL-23/IL-17 pathway in inflammatory bowel disease |
| Q42321105 | The LTi cell, an immunologic chameleon |
| Q53720556 | The Mouse Model of Infection with Citrobacter rodentium. |
| Q64248384 | The Natural Cytotoxicity Receptors in Health and Disease |
| Q26799454 | The Newly Identified T Helper 22 Cells Lodge in Leukemia |
| Q28076400 | The Potential Role of T Helper Cell 22 and IL-22 in Immunopathogenesis of Multiple Sclerosis |
| Q36947949 | The Role of IL-22 in Viral Infections: Paradigms and Paradoxes |
| Q64236840 | The Role of Plasmacytoid Dendritic Cells in Gut Health |
| Q99241373 | The adaptor protein CARD9, from fungal immunity to tumorigenesis |
| Q35592370 | The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic myeloid leukemia |
| Q35713322 | The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells |
| Q38319907 | The biology of innate lymphoid cells |
| Q34854990 | The cationic cytokine IL-26 differentially modulates virus infection in culture |
| Q38875858 | The composition and differentiation potential of the duodenal intraepithelial innate lymphocyte compartment is altered in coeliac disease |
| Q36711915 | The development of adult innate lymphoid cells |
| Q37619174 | The evolution of innate lymphoid cells |
| Q34152180 | The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. |
| Q36264109 | The gastrointestinal tract: properties and role in allogeneic hematopoietic stem cell transplantation. |
| Q26783887 | The mucosal immune system: From dentistry to vaccine development |
| Q92229836 | The neuropeptide VIP confers anticipatory mucosal immunity by regulating ILC3 activity |
| Q26740079 | The origin and role of innate lymphoid cells in the lung |
| Q90589872 | The pathogenic role of innate lymphoid cells in autoimmune-related and inflammatory skin diseases |
| Q54224246 | The role of IL-22 in the resolution of sterile and nonsterile inflammation. |
| Q34151076 | The role of Th17 cytokines in primary mucosal immunity |
| Q38184626 | The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sjögren's syndrome. |
| Q35740637 | The role of innate immunity in the host defense against intestinal bacterial pathogens |
| Q48146269 | The role of innate lymphoid cells in health and disease |
| Q89665184 | The role of innate lymphoid cells in response to microbes at mucosal surfaces |
| Q88990682 | The role of killer-cell immunoglobulin-like receptor (KIR) genes in susceptibility to inflammatory bowel disease: systematic review and meta-analysis |
| Q35155994 | The secretion of IL-22 from mucosal NKp44⁺ NK cells is associated with microbial translocation and virus infection in SIV/SHIV-infected Chinese macaques |
| Q42262891 | The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells. |
| Q34087033 | The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma. |
| Q38003085 | The transition of acute to chronic bowel inflammation in spondyloarthritis |
| Q38478216 | The unusual suspects--innate lymphoid cells as novel therapeutic targets in IBD. |
| Q36815662 | Thymus: the next (re)generation |
| Q39255569 | Tissue adaptation: Implications for gut immunity and tolerance. |
| Q91730073 | Tissue-resident memory-like ILCs: innate counterparts of TRM cells |
| Q37684372 | Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells |
| Q35694098 | Tissue-resident natural killer cells and their potential diversity |
| Q38089253 | Tissue-specific effector functions of innate lymphoid cells. |
| Q37733573 | Toll-like receptor 4-induced IL-22 accelerates kidney regeneration. |
| Q36311181 | Transcription Factor Bcl11b Controls Identity and Function of Mature Type 2 Innate Lymphoid Cells |
| Q41529922 | Transcription factor Dlx3 induces aryl hydrocarbon receptor promoter activity |
| Q24629126 | Transcription factor RORα is critical for nuocyte development |
| Q38192561 | Transcription factors controlling development and function of innate lymphoid cells |
| Q27005868 | Transcriptional control of innate lymphoid cells |
| Q35213159 | Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets |
| Q38525099 | Transcriptional regulation of innate lymphoid cell fate. |
| Q37712418 | Transcriptional regulators dictate innate lymphoid cell fates |
| Q64065227 | Transient Expression of GATA3 in Hematopoietic Stem Cells Facilitates Helper Innate Lymphoid Cell Differentiation |
| Q28829881 | Transient inhibition of ROR-γt therapeutically limits intestinal inflammation by reducing TH17 cells and preserving group 3 innate lymphoid cells |
| Q53489723 | Tumor necrosis factor-like weak inducer of apoptosis regulates the phenotype and cytotoxic activity of goat uterine natural killer cells. |
| Q61807031 | Type 3 ILCs in Lung Disease |
| Q90388993 | Type 3 Immunity during Clostridioides difficile Infection: Too Much of a Good Thing? |
| Q53533655 | Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis. |
| Q36180686 | Unique and redundant functions of NKp46+ ILC3s in models of intestinal inflammation |
| Q36426325 | Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance |
| Q48832494 | Visualization of IL-22-expressing Lymphocytes Using Reporter Mice. |
| Q39763196 | Vitamin A Controls the Presence of RORγ+ Innate Lymphoid Cells and Lymphoid Tissue in the Small Intestine |
| Q91610516 | Vitamin D/Vitamin D Receptor Signaling Is Required for Normal Development and Function of Group 3 Innate Lymphoid Cells in the Gut |
| Q33786520 | WASH maintains NKp46+ ILC3 cells by promoting AHR expression |
| Q28079656 | When Insult Is Added to Injury: Cross Talk between ILCs and Intestinal Epithelium in IBD |
| Q50673833 | [Innate lymphoid cells: new players of the mucosal immune response]. |
| Q52765682 | [Innate lymphoid cells]. |
Search more.